Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000950170-25-090428

Chief Executive Officer sold 26,491 shares at $6.80 ($180,139)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Barrow Robert Chief Executive Officer 2025-06-25 Sale 10b5-1 −26,491 $6.80 $180,139 830,065 D: show line 1 in the form
Open-market sales · 26,491 sh · avg $6.80 · $180,139
Loading xslF345X05/ownership.xml…